Vaccine politicization and care
19
Oct
Last Wednesday (10/14) the Ministry of Health of Brazil presented
to the states’ health secretaries a vaccination schedule against the covid-19 that would start in April 2021, the forecast is for the AstraZeneca vaccine, developed in partnership with the University of Oxford, which is in the third testing phase and should be produced in Brazil by FioCruz, in Manguinhos, in the state of Rio de Janeiro.
Some governors, in particular the state government of São Paulo, have interests in the Chinese company Sinovac, although China is also betting on the Oxford vaccine, this vaccine is being tested by the Butantan Institute of the University of São Paulo, and the Secretary of Health of São Paulo Jean Gorinchteyn told newspapers in São Paulo that “vaccines are not being treated in a republican way by the Ministry of Health, since the Chinese vaccine may have 46 million doses available in December and another 14 million by February 2021 and 40 million by June 2021.
But the dispute does not stop there, the American giant Pfizer announced on Friday (16/10) that it can apply for an “emergency” authorization for its vaccine against covid-19 until the end of November, said Albert Bourla, CEO of the group in a letter published on social media: “Let it be clear, assuming the data is positive, Pfizer will request an emergency use authorization in the United States shortly after the security step, in the third week of November, which indicates that it also wants to participate in the dispute, although it starts vaccination in the USA.
Because of a request from the German partner BioNTech, there was a request for a 2-month wait for the second dose of the vaccine (this vaccine is in two doses), but Albert Bourla shows politicization by stating that “we could know if our vaccine is effective or not at the end of October ”, I remember that the American elections take place on November 3, and this would be an asset for Donald Trumph.
According to the World Health Organization, and infectious disease Claudio Stadnik da Santa Casa, only 10 vaccines are in phase III, and the forecast if the schedule is followed, only vaccines from AstraZeneca / Oxford, Sinopharm (China) / Wuhan Institute of Biological Products (China) and Sinopharm (China) / Beijing Institute of Biological Products (China) would be ready in July 2021 while Moderna (USA) and Sinovac / Biotech (China) in October 2021.
So politics aside, this would be the real picture following the sanitary and medical precepts, to anticipate is to give possibility to error and lives are at stake.
See the graphic above: Source: World Health Organization and Cláudio Stadnik, infectologist at Santa Casa Hospital in Brazil.
